Cthrc1 overexpression is an independent prognostic marker in gastric cancer

Human Pathology

Volumn 45, Issue 5, 2014, Pages 1031-1038

  Gu, Lina ^a   Liu, Lei ^a   Zhong, Lili ^b   Bai, Yuxian ^a   Sui, Hong ^a   Wei, Xiaoli ^a   Zhang, Wenjie ^a   Huang, Peng ^a   Gao, Dandan ^a   Kong, Ying ^a   Lou, Ge ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Collagen triple helix repeat containing 1; Gastric carcinoma; Immunohistochemistry; Prognosis; Survival

Indexed keywords

COLLAGEN TRIPLE HELIX REPEAT CONTAINING 1; GASTRIC CARCINOMA; IMMUNOHISTOCHEMISTRY; PROGNOSIS; SURVIVAL;

ADULT; AGED; CHINA; DISEASE-FREE SURVIVAL; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS;

EID: 84898780660     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.12.020     Document Type: Article

References (35)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
2. S.R. Smalley, J.K. Benedetti, and D.G. Haller et al. Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection J Clin Oncol 30 2012 2327 2333
3. H.C. Jeung, Y.W. Moon, and S.Y. Rha et al. Phase III trial of adjuvant 5-fluorouracil and adriamycin versus 5-fluorouracil, adriamycin, and polyadenylic-polyuridylic acid (poly A:U) for locally advanced gastric cancer after curative surgery: final results of 15-year follow-up Ann Oncol 19 2008 520 526
4. L.L. Cheng, Y. Itahana, and Z.D. Lei et al. TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep) Clin Cancer Res 18 2012 4201 4212
5. B.P. van Rees, A. Musler, and E. Caspers et al. K-ras mutations in gastric stump carcinomas and in carcinomas from the non-operated stomach Hepatogastroenterology 46 1999 2063 2068
6. G.H. Lee, Y.E. Joo, and Y.S. Koh et al. Expression of survivin in gastric cancer and its relationship with tumor angiogenesis Eur J Gastroenterol Hepatol 18 2006 957 963
7. S.P. Tu, X.H. Jiang, and M.C. Lin et al. Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer Cancer Res 63 2003 7724 7732
8. Y.P. Liu, Y. Ling, and Q.F. Qi et al. The effects of ERCC1 expression levels on the chemosensitivity of gastric cancer cells to platinum agents and survival in gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy Oncol Lett 5 2013 935 942
9. C.B. Moelans, A.N. Milne, F.H. Morsink, G.J. Offerhaus, and P.J. van Diest Low frequency of HER2 amplification and overexpression in early onset gastric cancer Cell Oncol (Dordr) 34 2011 89 95
10. M.S. Lee, E.Y. Cha, P.T. Thuong, J.Y. Kim, M.S. Ahn, and J.Y. Sul Down-regulation of human epidermal growth factor receptor 2/neu oncogene by corosolic acid induces cell cycle arrest and apoptosis in NCI-N87 human gastric cancer cells Biol Pharm Bull 33 2010 931 937
11. M.F. Bellini, A.C. Cadamuro, M. Succi, M.A. Proenca, and A.E. Silva Alterations of the TP53 gene in gastric and esophageal carcinogenesis J Biomed Biotechnol 2012 2012 891961
12. P. Pyagay, M. Heroult, and Q. Wang et al. Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration Circ Res 96 2005 261 268
13. L. Tang, D.L. Dai, M. Su, M. Martinka, G. Li, and Y. Zhou Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers Clin Cancer Res 12 2006 3716 3722
14. W. Ip, O. Wellman-Labadie, and L. Tang et al. Collagen triple helix repeat containing 1 promotes melanoma cell adhesion and survival J Cutan Med Surg 15 2011 103 110
15. M. Orloff, C. Peterson, and X. He et al. Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma JAMA 306 2011 410 419
16. Z.S. Zhao, Y.Y. Wang, Y.Q. Chu, Z.Y. Ye, and H.Q. Tao SPARC is associated with gastric cancer progression and poor survival of patients Clin Cancer Res 16 2010 260 268
17. P. Hermanek The superiority of the new International Union Against Cancer and American Joint Committee on Cancer TNM staging of gastric carcinoma Cancer 88 2000 1763 1765
18. M.F. de Maat, C.J. van de Velde, and N. Umetani et al. Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer J Clin Oncol 25 2007 4887 4894
19. M. Hayashi, M. Inokuchi, and Y. Takagi et al. High expression of HER3 is associated with a decreased survival in gastric cancer Clin Cancer Res 14 2008 7843 7849
20. D. Chatterjee, E. Sabo, R. Tavares, and M.B. Resnick Inverse association between Raf kinase inhibitory protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome Clin Cancer Res 14 2008 2994 3001
21. F. De Vita, F. Giuliani, N. Silvestris, G. Catalano, F. Ciardiello, and M. Orditura Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target Cancer Treat Rev 36 Suppl. 3 2010 S11 S15
22. G. Turashvili, J. Bouchal, and K. Baumforth et al. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis BMC Cancer 7 2007 55
23. J. Li, Z. Zhang, and G. Li Patient outcome prediction using multiple biomarkers in human melanoma: a clinicopathological study of 118 cases Exp Ther Med 2 2011 131 135
24. F. Tan, F. Liu, H. Liu, Y. Hu, D. Liu, and G. Li CTHRC1 is associated with peritoneal carcinomatosis in colorectal cancer: a new predictor for prognosis Med Oncol 30 2013 473
25. E.H. Park, S. Kim, and J.Y. Jo et al. Collagen triple helix repeat containing-1 promotes pancreatic cancer progression by regulating migration and adhesion of tumor cells Carcinogenesis 34 2013 694 702
26. G. Kharaishvili, M. Cizkova, K. Bouchalova, G. Mgebrishvili, Z. Kolar, and J. Bouchal Collagen triple helix repeat containing 1 protein, periostin and versican in primary and metastatic breast cancer: an immunohistochemical study J Clin Pathol 64 2011 977 982
27. P. Wang, Y.C. Wang, and X.Y. Chen et al. CTHRC1 is upregulated by promoter demethylation and transforming growth factor-beta1 and may be associated with metastasis in human gastric cancer Cancer Sci 103 2012 1327 1333
28. M.W. Kelley Leading Wnt down a PCP path: Cthrc1 acts as a coreceptor in the Wnt-PCP pathway Dev Cell 15 2008 7 8
29. V.S. Golubkov, A.V. Chekanov, and P. Cieplak et al. The Wnt/planar cell polarity protein-tyrosine kinase-7 (PTK7) is a highly efficient proteolytic target of membrane type-1 matrix metalloproteinase: implications in cancer and embryogenesis J Biol Chem 285 2010 35740 35749
30. B.J. Dicken, D.L. Bigam, C. Cass, J.R. Mackey, A.A. Joy, and S.M. Hamilton Gastric adenocarcinoma: review and considerations for future directions Ann Surg 241 2005 27 39
31. Y. Lin, J. Ueda, and S. Kikuchi et al. Comparative epidemiology of gastric cancer between Japan and China World J Gastroenterol 17 2011 4421 4428
32. D. Ichikawa, H. Koike, and H. Ikoma et al. Detection of aberrant methylation as a tumor marker in serum of patients with gastric cancer Anticancer Res 24 2004 2477 2481
33. N. Tani, D. Ichikawa, and D. Ikoma et al. Circulating cell-free mRNA in plasma as a tumor marker for patients with primary and recurrent gastric cancer Anticancer Res 27 2007 1207 1212
34. N. Li, J. Zhang, and Y. Liang et al. A controversial tumor marker: is SM22 a proper biomarker for gastric cancer cells? J Proteome Res 6 2007 3304 3312
35. J.H. Kim, T.H. Baek, and H.S. Yim et al. Collagen triple helix repeat containing-1 (CTHRC1) expression in invasive ductal carcinoma of the breast: the impact on prognosis and correlation to clinicopathologic features Pathol Oncol Res 19 2013 731 737